Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag, commonly known as Egis, is a prominent pharmaceutical company headquartered in Hungary (HU). Established in 1888, Egis has evolved into a key player in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of generic and innovative medicines. With a strong presence in Central and Eastern Europe, Egis is renowned for its diverse portfolio, which includes prescription drugs, over-the-counter products, and active pharmaceutical ingredients. The company is distinguished by its commitment to quality and innovation, consistently achieving significant milestones in research and development. Egis holds a notable market position, recognised for its contributions to healthcare and its robust pipeline of products that cater to various therapeutic areas. Through its dedication to excellence, Egis continues to enhance patient care and solidify its reputation as a trusted name in the pharmaceutical sector.
How does Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag's score of 55 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag, headquartered in Hungary (HU), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company is a current subsidiary of Les Laboratoires Servier, SAS, and any climate commitments or emissions performance data may be inherited from this parent organisation. As of now, there are no documented reduction targets or climate pledges from Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag. The absence of specific initiatives or targets suggests that the company may still be in the process of developing its climate strategy or reporting framework. Given the context of its corporate family relationship, it is advisable to monitor emissions and climate commitments from Les Laboratoires Servier, SAS, as these may influence Egis Gyogyszergyar's future sustainability initiatives and performance metrics.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 62,044,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 54,578,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - | - | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Egis Gyogyszergyar Nyilvanosan Mukodo Reszvenytarsasag has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.